SlideShare a Scribd company logo
1
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove
Research Institute
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Addressing	Health	Dispari1es	in	Cancer	Care:	
From	the	Bench	to	the	Bedside	and	Beyond	
Darrell	M.	Gray,	II,	MD,	MPH		
darrell.gray@osumc.edu	
@DMGrayMD
2
Berwick	D	et	al.	Health	Affairs	2008;	27(3):759-769.
4
“For	the	loved	ones	we’ve	all	lost,	for	the	families	we	
can	s6ll	save,	let’s	make	America	the	country	that	cures	
cancer	once	and	for	all.”	
	
President	Obama,	State	of	the	Union	Address,		
January	12,	2016
5
§  McCarthy	AM	et	al.	JCO	2016	May	9.	[Epub	ahead	of	print].	
§  3,016	women	with	invasive	breast	ca,	808	oncologists,	and	732	
surgeons.	
§  Black	women	less	likely	to	undergo	BRCA	1/2	tes1ng	than	white	
women	(OR	0.66;	95%CI,	0.53-0.81)	
§  Care	highly	segregated	across	surgeons	and	oncologists	
§  Black	women	less	likely	to	receive	a	physician	recommenda1on	for	
tes1ng	(OR	0.66;	95%	CI	0.54-0.82)	
	
6
We	face	the	challenge	of	inequi1es	in	cancer	care	and	
applica1on	of	new	knowledge
§  Eggly	S	et	al.	Health	Expect	2015;	18(5):1316-26.	
§  Visits	with	African	American	pa1ents	(n=11)	that	included	a	
clinical	trial	offer	were	matched	to	a	sample	of	visits	with	White	
pa1ents	(n=11).	
§  Visits	with	African	American	pa1ents	were	
§  Shorter	with	few	men1ons	of	and	less	discussion	of	clinical	trials	
§  Less	discussion	of	purpose	and	risks	of	offered	trial(s)	
§  More	discussion	of	voluntary	par1cipa1on	
7
We	face	the	challenge	of	inequi1es	in	cancer	care	and	
applica1on	of	new	knowledge
§  Implicit	bias	contributes	to	disparate	outcomes.	
§  Hall	WJ	et	al.	Am	J	Public	Health	2015;	105(12):e60-76.	
§  Systema1c	review	including	15	studies	
§  Implicit	bias	has	an	adverse	impact	on	the	following:	
§  Pa1ent-provider	interac1ons	
§  Treatment	decisions	
§  Treatment	adherence	
§  Pa1ent	health	outcomes	
8
We	face	the	challenge	of	inequi1es	in	cancer	care	
and	applica1on	of	new	knowledge
§  Implicit	bias	contributes	to	disparate	outcomes.	
§  Example:	Thrombolysis	for	ACS	(Green	AR	et	al.	J	Gen	Intern	Med	
2007;	22(9):	1231-1238.	
§  Study	of	287	residents	at	4	academic	medical	centers	
§  Implicit	bias	measures	revealed	the	following:	
§  Preference:	White	>	Black	pa1ents	
§  Percep1on:	Blacks	less	coopera1ve	with	procedures	and	less	
coopera1ve	generally	
§  As	pro-White	bias	é	so	did	the	likelihood	of	trea1ng	white	
pa1ents	and	not	trea1ng	Blacks.	
9
We	face	the	challenge	of	inequi1es	in	cancer	care	
and	applica1on	of	new	knowledge
§  Clinical	trials	
§  1%	of	trial	par1cipants	are	Hispanic.	
§  5%	of	trial	par1cipants	are	African	American.	
§  Biobanking	programs	
§  Only	9.94%	of	cases	in	The	Cancer	Genome	Atlas	(NCI-supported)	
were	collected	from	racial/ethnic	minori1es.	
10
Racial/ethnic	minori1es	are	underrepresented	in	
clinical	trials	and	biobanking	programs	
			This	is	less	of	a	func1on	of	minori1es’	unwillingness	to	par1cipate	in	such		
programs	and	more	of	a	reflec1on	of	the	lack	of	recommenda1on	and	access.	
	
Hagiwara	N	et	al.	J	Cancer	Educ	2014;	29:580-587.	
Wendler	D	et	al.	PLoS	Med	2006;	3(2):e19.
11
Race	alone	does	not	fully	explain	dispari1es	in	the	
cancer	care	con1nuum:	The	example	of	CRC	
Jemal	A	et	al.	J	Clin	Oncol	doi:	10.1200/JCO.2014.58.7519
12
Race	alone	does	not	fully	explain	dispari1es	in	the	
cancer	care	con1nuum:	The	example	of	CRC
Adjusted	Colorectal	Cancer	Survival	by	Stage	and	Insurance	Status	
among	White	Pa1ents	18-64	years	Diagnosed	from	1999-2000,	NCDB	
Figure	courtesy	of	Dr.	O1s	Brawley,	American	Cancer	Society	
Stage	I,	privately	insured	
Stage	II,	privately	insured	
Stage	I,	uninsured/Medicaid	
Stage	II,	uninsured/Medicaid
13
Race	alone	does	not	fully	explain	dispari1es	in	the	
cancer	care	con1nuum:	The	example	of	CRC
Siegel	RL	et	al.	Cancer	Epidemiol	Biomarkers	Prev;24(8):	1151-6.	
Geographic “hot spots”
for CRC deaths
14
Utilization
of Care
Access
to Care
Delivery
of
Services
Pa1ent	Factors:	
- 	Economic	
- 	Social	
- 	Behavioral	
- 	Geographic	
- 	Literacy	
Provider	Factors:	
- 	Poor	communica1on	
- 	Limited	cultural		
			competence	
- 	Clinical	uncertainty	
- 	Bias/Stereotypes	
	
Adapted	from	Unequal	Treatment:	Confron1ng	Racial	and	Ethnic	Dispari1es	in	Health	Care	(2003).	
Summary
“True	compassion	is	more	than	flinging	a	coin	to	a	beggar;	it	
understands	that	an	edifice	which	produces	beggars	needs	
restructuring.”	
	
-	Dr.	Mar1n	L.	King,	Jr.	
15
§  How	can	we	provide	adequate	high	quality	and	high	value	
care	to	por1ons	of	the	popula1on	that	too	open	do	not	
receive	it?	
	 		
§  What	can	I	do?	What	should	I	do?	What	must	I	do?	
16
Fundamental	scien1fic	and	moral	ques1ons
17
We	must	address	all	determinants	of	health	
Adapted	from	McGinnis	JM	et	al.	Health	Affairs	2002;	21(2):	78-93
“It	is	much	more	important	to	know	what	sort	of	a	
pa1ent	has	a	disease	than	what	sort	of	a	disease	a	
pa1ent	has.”	
-	Sir	William	Osler	
18
§  Refining	data	collec1on	and	performance	measurement	and	
monitoring.	
§  Exploring	the	role	of	genomics	and	pharmacogenomics	in	
health	dispari1es	as	we	build	personalized	medicine	strategies.	
§  Leveraging	health	informa1on	technology	to	engage,	study,	
and	inform	pa1ents	and	deliver	quality	care	equitably.	
19
Opportuni1es	to	address	health	dispari1es	from	the	
bench
§  Awareness	of	implicit	biases	
§  hrps://implicit.harvard.edu/implicit/takeatest.html		
§  Cross-cultural	communica1on	training	of	doctors,	nurses	and	
staff	
§  Engagement	of	pa1ents	in	biobanking	and	discussions	about	
clinical	trials	
§  Use	of	evidence-based	interven1ons	to	overcome	barriers	to	
access	and	care	delivery	
§  Example:	Pa1ent	navigators	
20
Opportuni1es	to	address	health	dispari1es	from	the	
bedside
§  Tackle	cri1cal	shortage	of	African	American	medical	oncologists.1	
§  2.3%	of	oncologists	in	the	US;	4.0%	of	heme/onc	fellows	in	the	US	
§  Enhance	programs	and	policies	that	address	barriers	along	the	
cancer	care	con1nuum.	
§  Examples	include:	
§  The	Delaware	Experiment2	
§  Project	Access	in	San	Diego	(unpublished	experience)	
§  PACE	Program	at	OSU	(unpublished	experience)	
21
Opportuni1es	to	address	health	dispari1es	in	the	
community	and	beyond	
1.  Hamel	LM	et	al.	J	Clin	Oncol	2015;	33(32):3697-700.	
2.  Grubbs	SS	et	al.	J	Clin	Oncol	2013;	31(16):	1928-30
“Each	1me	a	man	stands	up	for	an	ideal,	or	acts	to	improve	
the	lot	of	others,	or	strikes	out	against	injus1ce,	he	sends	
forth	a	1ny	ripple	of	hope,	and	those	ripples	build	a	current	
which	can	sweep	down	the	migh1est	walls	of	oppression	
and	resistance.”	
	
	-	Robert	F.	Kennedy	
22
A	Call	to	Ac1on
Darrell	M.	Gray,	II,	MD,	MPH	
Deputy	Director,	Center	for	Cancer	Health	Equity	
OSUCCC-The	James	Cancer	Hospital	&	Solove	Research	Ins1tute	
Assistant	Professor,	Division	of	Gastroenterology	
The	Ohio	State	University	Wexner	Medical	Center	
darrell.gray@osumc.edu	
@DMGrayMD	
23
Thank	you!
24
hrp://interac1onins1tute.org/illustra1ng-equality-vs-equity/	
Ques1ons?
Courtesy	of	David	Norris,	Senior	Researcher,	The	Kirwan	Ins1tute	
25
Bonus	slides	on	dealing	with	implicit	bias
Dealing	with	Implicit	Bias	
Discover	your	implicit	biases	
§  IB’s	cannot	be	accessed		
through	introspec1on	
§  Take	the	IAT	(or	several	IAT’s;		
many	available)	
§  8	million	tests	taken	since	1998	
§  Google	“Harvard	IAT”	or		
“Implicit	Associa1on	Test”	or		
“Project	Implicit”	
§  Be	good	to	yourself	
§  Remember:	We	ALL	have	implicit	biases	26
Dealing	with	Implicit	Bias	
Commit	to	Egalitarian	Goals	
Medical	students	should	be		
“encouraged	to	approach	every	
encounter	with	pa1ents	who	are	
members	of	underprivileged	or	
stereotyped	social	groups	as	an		
opportunity	to	reinforce	and	act	out	their	avowed	
commitment	to	[egalitarian]	values”	(Byrne	&	
Tanesini,	2015,	p.	1259).		
27
Dealing	with	Implicit	Bias	
Engage	in	“effor9ul,	delibera<ve	
processing”	in	the	moment	
§  Spontaneous	judgments	provoke	
reliance	on	stereotypes	
§  Delibera1ve	processing:	
§  Self-monitor	your	behaviors	to	
offset	implicit	stereotyping	
§  Rethink	the	standard	ways	pa1ent	
are	classified	(race/ethnicity,	gender,	etc.)	
§  Instead,	focus	on	a	common	iden1ty	you	share	with	
each	pa1ent	
28
Dealing	with	Implicit	Bias	
Reduce	your	cogni<ve	load	
(to	the	extent	you	are	able)	
§  Reduced	cogni1ve	load	=		
more	1me	to	process,	less	
biased	decision-making	
§  How?	
§  Restructure	you	day	(e.g.,		
do	hardest	tasks	in	the		
morning)	
§  Advocate	for	changes	in	healthcare	
workflow,	sevng	(brainstorm	with	colleagues)	
29
Dealing	with	Implicit	Bias	
Intergroup	contact	
§  Meaningful	engagement	w/	people	whose	iden11es	differ	
from	your	own	
§  Build	new	“other”	group	associa1ons	
§  Break	down	exis1ng	implicit	associa1ons	
§  For	op1mal	effect,	should	be:	
§  Coopera1ve	sevng	
§  Working	toward	a		
common	goal	
§  ***Equal	status***	
		(Be	aware	of	power	
			dynamics)	
30

More Related Content

What's hot

ASCO 2016 Breast Cancer Review
ASCO 2016 Breast Cancer ReviewASCO 2016 Breast Cancer Review
ASCO 2016 Breast Cancer Review
OSUCCC - James
 
Jnma00303 0020
Jnma00303 0020Jnma00303 0020
Jnma00303 0020
Kyaw Shein
 
Kiow 11 2017 metastatic colon cancer from bench to clinic
Kiow 11 2017 metastatic colon cancer from bench to clinicKiow 11 2017 metastatic colon cancer from bench to clinic
Kiow 11 2017 metastatic colon cancer from bench to clinic
Mohamed Abdulla
 
New Trends in the Management of Metastatic Prostate Cancer
New Trends in the Management of Metastatic Prostate CancerNew Trends in the Management of Metastatic Prostate Cancer
New Trends in the Management of Metastatic Prostate Cancer
flasco_org
 
The grey zone in prostate cancer management
The grey zone in prostate cancer managementThe grey zone in prostate cancer management
The grey zone in prostate cancer management
Mohamed Abdulla
 
METASTATC COLORECTAL CANCER IN 2017
METASTATC COLORECTAL CANCER IN 2017METASTATC COLORECTAL CANCER IN 2017
METASTATC COLORECTAL CANCER IN 2017
Mohamed Abdulla
 
Aristolochic acids in herbal medicine cause cancer
Aristolochic acids in herbal medicine cause cancerAristolochic acids in herbal medicine cause cancer
Aristolochic acids in herbal medicine cause cancer
Steve Rozen
 
Liver limited Metastatic Colorectal Cancer. Case Presentation
Liver limited Metastatic Colorectal Cancer. Case PresentationLiver limited Metastatic Colorectal Cancer. Case Presentation
Liver limited Metastatic Colorectal Cancer. Case Presentation
Mohamed Abdulla
 
Advancing The Prevention And Cure Of Cancer
Advancing The Prevention And Cure Of CancerAdvancing The Prevention And Cure Of Cancer
Advancing The Prevention And Cure Of Cancerfondas vakalis
 
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
bkling
 
Management of metastatic colorectal cancer
Management of metastatic colorectal cancerManagement of metastatic colorectal cancer
Management of metastatic colorectal cancer
Mohamed Abdulla
 
Lorlatinib alk positive lung cancer
Lorlatinib alk positive lung cancerLorlatinib alk positive lung cancer
Lorlatinib alk positive lung cancer
Prof. Shad Salim Akhtar
 
What 2015 Holds for Colorectal Cancer #CRCWebinar
What 2015 Holds for Colorectal Cancer #CRCWebinarWhat 2015 Holds for Colorectal Cancer #CRCWebinar
What 2015 Holds for Colorectal Cancer #CRCWebinar
Fight Colorectal Cancer
 
Ohio States 2016 ASH Review Blood and Marrow Transplantation
Ohio States 2016 ASH Review Blood and Marrow TransplantationOhio States 2016 ASH Review Blood and Marrow Transplantation
Ohio States 2016 ASH Review Blood and Marrow Transplantation
OSUCCC - James
 
Owen Patrick Smith , Prof of Haematology, Trinity College Dublin
Owen Patrick Smith , Prof of Haematology, Trinity College DublinOwen Patrick Smith , Prof of Haematology, Trinity College Dublin
Owen Patrick Smith , Prof of Haematology, Trinity College Dublin
Investnet
 
Expanding treatment platform in m crc bayer - asyut 2018
Expanding treatment platform in m crc   bayer - asyut 2018Expanding treatment platform in m crc   bayer - asyut 2018
Expanding treatment platform in m crc bayer - asyut 2018
Mohamed Abdulla
 
Everything you need to know about moa of bone targeted agents amgen 2017
Everything you need to know about moa of bone targeted agents amgen 2017Everything you need to know about moa of bone targeted agents amgen 2017
Everything you need to know about moa of bone targeted agents amgen 2017
Mohamed Abdulla
 
Cancer estadisticas-Dr peñaloza
Cancer estadisticas-Dr peñalozaCancer estadisticas-Dr peñaloza
Cancer estadisticas-Dr peñaloza
Clinica de imagenes
 

What's hot (20)

ASCO 2016 Breast Cancer Review
ASCO 2016 Breast Cancer ReviewASCO 2016 Breast Cancer Review
ASCO 2016 Breast Cancer Review
 
Jnma00303 0020
Jnma00303 0020Jnma00303 0020
Jnma00303 0020
 
Kiow 11 2017 metastatic colon cancer from bench to clinic
Kiow 11 2017 metastatic colon cancer from bench to clinicKiow 11 2017 metastatic colon cancer from bench to clinic
Kiow 11 2017 metastatic colon cancer from bench to clinic
 
New Trends in the Management of Metastatic Prostate Cancer
New Trends in the Management of Metastatic Prostate CancerNew Trends in the Management of Metastatic Prostate Cancer
New Trends in the Management of Metastatic Prostate Cancer
 
The grey zone in prostate cancer management
The grey zone in prostate cancer managementThe grey zone in prostate cancer management
The grey zone in prostate cancer management
 
METASTATC COLORECTAL CANCER IN 2017
METASTATC COLORECTAL CANCER IN 2017METASTATC COLORECTAL CANCER IN 2017
METASTATC COLORECTAL CANCER IN 2017
 
SELECT trial 2009
SELECT trial 2009SELECT trial 2009
SELECT trial 2009
 
4625.full
4625.full4625.full
4625.full
 
Aristolochic acids in herbal medicine cause cancer
Aristolochic acids in herbal medicine cause cancerAristolochic acids in herbal medicine cause cancer
Aristolochic acids in herbal medicine cause cancer
 
Liver limited Metastatic Colorectal Cancer. Case Presentation
Liver limited Metastatic Colorectal Cancer. Case PresentationLiver limited Metastatic Colorectal Cancer. Case Presentation
Liver limited Metastatic Colorectal Cancer. Case Presentation
 
Advancing The Prevention And Cure Of Cancer
Advancing The Prevention And Cure Of CancerAdvancing The Prevention And Cure Of Cancer
Advancing The Prevention And Cure Of Cancer
 
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
 
Management of metastatic colorectal cancer
Management of metastatic colorectal cancerManagement of metastatic colorectal cancer
Management of metastatic colorectal cancer
 
Lorlatinib alk positive lung cancer
Lorlatinib alk positive lung cancerLorlatinib alk positive lung cancer
Lorlatinib alk positive lung cancer
 
What 2015 Holds for Colorectal Cancer #CRCWebinar
What 2015 Holds for Colorectal Cancer #CRCWebinarWhat 2015 Holds for Colorectal Cancer #CRCWebinar
What 2015 Holds for Colorectal Cancer #CRCWebinar
 
Ohio States 2016 ASH Review Blood and Marrow Transplantation
Ohio States 2016 ASH Review Blood and Marrow TransplantationOhio States 2016 ASH Review Blood and Marrow Transplantation
Ohio States 2016 ASH Review Blood and Marrow Transplantation
 
Owen Patrick Smith , Prof of Haematology, Trinity College Dublin
Owen Patrick Smith , Prof of Haematology, Trinity College DublinOwen Patrick Smith , Prof of Haematology, Trinity College Dublin
Owen Patrick Smith , Prof of Haematology, Trinity College Dublin
 
Expanding treatment platform in m crc bayer - asyut 2018
Expanding treatment platform in m crc   bayer - asyut 2018Expanding treatment platform in m crc   bayer - asyut 2018
Expanding treatment platform in m crc bayer - asyut 2018
 
Everything you need to know about moa of bone targeted agents amgen 2017
Everything you need to know about moa of bone targeted agents amgen 2017Everything you need to know about moa of bone targeted agents amgen 2017
Everything you need to know about moa of bone targeted agents amgen 2017
 
Cancer estadisticas-Dr peñaloza
Cancer estadisticas-Dr peñalozaCancer estadisticas-Dr peñaloza
Cancer estadisticas-Dr peñaloza
 

Viewers also liked

ASCO Review- 2015 What is new in breast cancer?
ASCO Review- 2015 What is new in breast cancer?ASCO Review- 2015 What is new in breast cancer?
ASCO Review- 2015 What is new in breast cancer?
OSUCCC - James
 
Melanoma ASCO Review Update 2016
Melanoma ASCO Review Update 2016Melanoma ASCO Review Update 2016
Melanoma ASCO Review Update 2016
OSUCCC - James
 
ASCO Review 2016 Colorectal Cancer
ASCO Review 2016 Colorectal CancerASCO Review 2016 Colorectal Cancer
ASCO Review 2016 Colorectal Cancer
OSUCCC - James
 
2015 ASCO Genitourinary Cancers Update
2015 ASCO Genitourinary Cancers Update2015 ASCO Genitourinary Cancers Update
2015 ASCO Genitourinary Cancers Update
OSUCCC - James
 
Ohio State's 2016 ASH Review T-cell Disorders
Ohio State's 2016 ASH Review T-cell DisordersOhio State's 2016 ASH Review T-cell Disorders
Ohio State's 2016 ASH Review T-cell Disorders
OSUCCC - James
 
Update on Systemic Therapy for Metastatic Pancreas Adenocarcinoma
Update on Systemic Therapy for Metastatic Pancreas AdenocarcinomaUpdate on Systemic Therapy for Metastatic Pancreas Adenocarcinoma
Update on Systemic Therapy for Metastatic Pancreas Adenocarcinoma
OSUCCC - James
 
Ohio State's 2016 ASH Review Blood and Marrow Trasplantation (with Turning Po...
Ohio State's 2016 ASH Review Blood and Marrow Trasplantation (with Turning Po...Ohio State's 2016 ASH Review Blood and Marrow Trasplantation (with Turning Po...
Ohio State's 2016 ASH Review Blood and Marrow Trasplantation (with Turning Po...
OSUCCC - James
 
Updates On Upper Gastrointestinal Malignancies 2015
Updates On Upper Gastrointestinal Malignancies 2015Updates On Upper Gastrointestinal Malignancies 2015
Updates On Upper Gastrointestinal Malignancies 2015
OSUCCC - James
 
(Ohio State's 2016 ASH Review) ASH 2015 REVIEW – LYMPHOMA ABSTRACTS
(Ohio State's 2016 ASH Review) ASH 2015 REVIEW – LYMPHOMA ABSTRACTS(Ohio State's 2016 ASH Review) ASH 2015 REVIEW – LYMPHOMA ABSTRACTS
(Ohio State's 2016 ASH Review) ASH 2015 REVIEW – LYMPHOMA ABSTRACTS
OSUCCC - James
 
ASCO 2016 Thoracic Review
ASCO 2016 Thoracic ReviewASCO 2016 Thoracic Review
ASCO 2016 Thoracic Review
OSUCCC - James
 
Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...
Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...
Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...
OSUCCC - James
 
Ohio State's 2016 ASH Review - ASH Review 2015 Acute Leukemias and MDS
Ohio State's 2016 ASH Review - ASH Review 2015Acute Leukemias and MDSOhio State's 2016 ASH Review - ASH Review 2015Acute Leukemias and MDS
Ohio State's 2016 ASH Review - ASH Review 2015 Acute Leukemias and MDS
OSUCCC - James
 
ASCO Review Benign Hematology
ASCO Review Benign HematologyASCO Review Benign Hematology
ASCO Review Benign Hematology
OSUCCC - James
 
Ohio State's 2016 ASH Review - Updates in Myeloproliferative Disorders, inclu...
Ohio State's 2016 ASH Review - Updates in Myeloproliferative Disorders, inclu...Ohio State's 2016 ASH Review - Updates in Myeloproliferative Disorders, inclu...
Ohio State's 2016 ASH Review - Updates in Myeloproliferative Disorders, inclu...
OSUCCC - James
 
Asco 2016 GU Review
Asco 2016 GU ReviewAsco 2016 GU Review
Asco 2016 GU Review
OSUCCC - James
 
ASCO 2016 Sarcoma Review
ASCO 2016 Sarcoma ReviewASCO 2016 Sarcoma Review
ASCO 2016 Sarcoma Review
OSUCCC - James
 
ASCO 2015 Melanoma Immunotherapy
ASCO 2015 Melanoma ImmunotherapyASCO 2015 Melanoma Immunotherapy
ASCO 2015 Melanoma Immunotherapy
OSUCCC - James
 
April, 2015 Presentation
April, 2015 PresentationApril, 2015 Presentation
April, 2015 Presentation
Imad Ali
 
Work for Pentasia
Work for PentasiaWork for Pentasia
Work for Pentasia
Luke Donovan-King
 
14. mitosis y meiosis
14. mitosis y meiosis14. mitosis y meiosis
14. mitosis y meiosis
granjacastro22
 

Viewers also liked (20)

ASCO Review- 2015 What is new in breast cancer?
ASCO Review- 2015 What is new in breast cancer?ASCO Review- 2015 What is new in breast cancer?
ASCO Review- 2015 What is new in breast cancer?
 
Melanoma ASCO Review Update 2016
Melanoma ASCO Review Update 2016Melanoma ASCO Review Update 2016
Melanoma ASCO Review Update 2016
 
ASCO Review 2016 Colorectal Cancer
ASCO Review 2016 Colorectal CancerASCO Review 2016 Colorectal Cancer
ASCO Review 2016 Colorectal Cancer
 
2015 ASCO Genitourinary Cancers Update
2015 ASCO Genitourinary Cancers Update2015 ASCO Genitourinary Cancers Update
2015 ASCO Genitourinary Cancers Update
 
Ohio State's 2016 ASH Review T-cell Disorders
Ohio State's 2016 ASH Review T-cell DisordersOhio State's 2016 ASH Review T-cell Disorders
Ohio State's 2016 ASH Review T-cell Disorders
 
Update on Systemic Therapy for Metastatic Pancreas Adenocarcinoma
Update on Systemic Therapy for Metastatic Pancreas AdenocarcinomaUpdate on Systemic Therapy for Metastatic Pancreas Adenocarcinoma
Update on Systemic Therapy for Metastatic Pancreas Adenocarcinoma
 
Ohio State's 2016 ASH Review Blood and Marrow Trasplantation (with Turning Po...
Ohio State's 2016 ASH Review Blood and Marrow Trasplantation (with Turning Po...Ohio State's 2016 ASH Review Blood and Marrow Trasplantation (with Turning Po...
Ohio State's 2016 ASH Review Blood and Marrow Trasplantation (with Turning Po...
 
Updates On Upper Gastrointestinal Malignancies 2015
Updates On Upper Gastrointestinal Malignancies 2015Updates On Upper Gastrointestinal Malignancies 2015
Updates On Upper Gastrointestinal Malignancies 2015
 
(Ohio State's 2016 ASH Review) ASH 2015 REVIEW – LYMPHOMA ABSTRACTS
(Ohio State's 2016 ASH Review) ASH 2015 REVIEW – LYMPHOMA ABSTRACTS(Ohio State's 2016 ASH Review) ASH 2015 REVIEW – LYMPHOMA ABSTRACTS
(Ohio State's 2016 ASH Review) ASH 2015 REVIEW – LYMPHOMA ABSTRACTS
 
ASCO 2016 Thoracic Review
ASCO 2016 Thoracic ReviewASCO 2016 Thoracic Review
ASCO 2016 Thoracic Review
 
Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...
Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...
Ohio State's 2016 ASH Review - BEST OF ASH 2015 MULTIPLE MYELOMA AND PLASMA C...
 
Ohio State's 2016 ASH Review - ASH Review 2015 Acute Leukemias and MDS
Ohio State's 2016 ASH Review - ASH Review 2015Acute Leukemias and MDSOhio State's 2016 ASH Review - ASH Review 2015Acute Leukemias and MDS
Ohio State's 2016 ASH Review - ASH Review 2015 Acute Leukemias and MDS
 
ASCO Review Benign Hematology
ASCO Review Benign HematologyASCO Review Benign Hematology
ASCO Review Benign Hematology
 
Ohio State's 2016 ASH Review - Updates in Myeloproliferative Disorders, inclu...
Ohio State's 2016 ASH Review - Updates in Myeloproliferative Disorders, inclu...Ohio State's 2016 ASH Review - Updates in Myeloproliferative Disorders, inclu...
Ohio State's 2016 ASH Review - Updates in Myeloproliferative Disorders, inclu...
 
Asco 2016 GU Review
Asco 2016 GU ReviewAsco 2016 GU Review
Asco 2016 GU Review
 
ASCO 2016 Sarcoma Review
ASCO 2016 Sarcoma ReviewASCO 2016 Sarcoma Review
ASCO 2016 Sarcoma Review
 
ASCO 2015 Melanoma Immunotherapy
ASCO 2015 Melanoma ImmunotherapyASCO 2015 Melanoma Immunotherapy
ASCO 2015 Melanoma Immunotherapy
 
April, 2015 Presentation
April, 2015 PresentationApril, 2015 Presentation
April, 2015 Presentation
 
Work for Pentasia
Work for PentasiaWork for Pentasia
Work for Pentasia
 
14. mitosis y meiosis
14. mitosis y meiosis14. mitosis y meiosis
14. mitosis y meiosis
 

Similar to ASCO Review 2016 Addressing Health Disparities

Cancer hospitals in georgia
Cancer hospitals in georgiaCancer hospitals in georgia
Cancer hospitals in georgia
Pratima Patil
 
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
Innovara, Inc.
 
Head & Neck Cancer Screening to Be Hosted by South Nassau, Senator Skelos
Head & Neck Cancer Screening to Be Hosted by South Nassau, Senator SkelosHead & Neck Cancer Screening to Be Hosted by South Nassau, Senator Skelos
Head & Neck Cancer Screening to Be Hosted by South Nassau, Senator Skelos
South Nassau Communities Hospital
 
Family First: What you need to know about family history, genetic testing, a...
Family First:  What you need to know about family history, genetic testing, a...Family First:  What you need to know about family history, genetic testing, a...
Family First: What you need to know about family history, genetic testing, a...
Fight Colorectal Cancer
 
The Latest in Colorectal Cancer Research
The Latest in Colorectal Cancer ResearchThe Latest in Colorectal Cancer Research
The Latest in Colorectal Cancer Research
Fight Colorectal Cancer
 
McGinnis-ShortBio update Nov.2013
McGinnis-ShortBio update Nov.2013McGinnis-ShortBio update Nov.2013
McGinnis-ShortBio update Nov.2013LaMar McGinnis
 
Cancer Awareness - Kaplan University Dept. of Public Health
Cancer Awareness - Kaplan University Dept. of Public HealthCancer Awareness - Kaplan University Dept. of Public Health
Cancer Awareness - Kaplan University Dept. of Public Health
smtibor
 
Call-on Congress 2014 Heather Hampel: Genetics
Call-on Congress 2014 Heather Hampel: GeneticsCall-on Congress 2014 Heather Hampel: Genetics
Call-on Congress 2014 Heather Hampel: Genetics
Fight Colorectal Cancer
 
Geriatric Oncology_ Treatment, Assessment and Management ( PDFDrive ).pdf
Geriatric Oncology_ Treatment, Assessment and Management ( PDFDrive ).pdfGeriatric Oncology_ Treatment, Assessment and Management ( PDFDrive ).pdf
Geriatric Oncology_ Treatment, Assessment and Management ( PDFDrive ).pdf
balaji jegannathan
 
Rodger - Prostate cancer mortality outcomes and patterns of primary treatment...
Rodger - Prostate cancer mortality outcomes and patterns of primary treatment...Rodger - Prostate cancer mortality outcomes and patterns of primary treatment...
Rodger - Prostate cancer mortality outcomes and patterns of primary treatment...
Cancer Council NSW
 
Precision Medicine at MSU
Precision Medicine at MSUPrecision Medicine at MSU
Precision Medicine at MSU
Michigan State University Research
 
33b-Cancer-21-6-2022.pdf
33b-Cancer-21-6-2022.pdf33b-Cancer-21-6-2022.pdf
33b-Cancer-21-6-2022.pdf
MazharulIslam777469
 
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
UCLA
 
MedicalResearch.com Top Medical Research Interview August 14 2015
MedicalResearch.com Top Medical Research Interview August 14 2015MedicalResearch.com Top Medical Research Interview August 14 2015
MedicalResearch.com Top Medical Research Interview August 14 2015
Marie Benz
 
When reducing cancer risk in our population, let’s not exacerbate disparities
When reducing cancer risk in our population, let’s not exacerbate disparitiesWhen reducing cancer risk in our population, let’s not exacerbate disparities
When reducing cancer risk in our population, let’s not exacerbate disparities
Graham Colditz
 
Academic Detailing v01.13.17
Academic Detailing v01.13.17Academic Detailing v01.13.17
Academic Detailing v01.13.17Nathaniel Tran
 
Cancer hospitals in illinois
Cancer hospitals in illinoisCancer hospitals in illinois
Cancer hospitals in illinois
Pratima Patil
 

Similar to ASCO Review 2016 Addressing Health Disparities (20)

Cancer hospitals in georgia
Cancer hospitals in georgiaCancer hospitals in georgia
Cancer hospitals in georgia
 
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
 
Head & Neck Cancer Screening to Be Hosted by South Nassau, Senator Skelos
Head & Neck Cancer Screening to Be Hosted by South Nassau, Senator SkelosHead & Neck Cancer Screening to Be Hosted by South Nassau, Senator Skelos
Head & Neck Cancer Screening to Be Hosted by South Nassau, Senator Skelos
 
Family First: What you need to know about family history, genetic testing, a...
Family First:  What you need to know about family history, genetic testing, a...Family First:  What you need to know about family history, genetic testing, a...
Family First: What you need to know about family history, genetic testing, a...
 
The Latest in Colorectal Cancer Research
The Latest in Colorectal Cancer ResearchThe Latest in Colorectal Cancer Research
The Latest in Colorectal Cancer Research
 
McGinnis-ShortBio update Nov.2013
McGinnis-ShortBio update Nov.2013McGinnis-ShortBio update Nov.2013
McGinnis-ShortBio update Nov.2013
 
CV Plastic
CV PlasticCV Plastic
CV Plastic
 
FINAL PROJECT-4-4-16
FINAL PROJECT-4-4-16FINAL PROJECT-4-4-16
FINAL PROJECT-4-4-16
 
Ortiz CV 12.15.16
Ortiz CV 12.15.16Ortiz CV 12.15.16
Ortiz CV 12.15.16
 
Cancer Awareness - Kaplan University Dept. of Public Health
Cancer Awareness - Kaplan University Dept. of Public HealthCancer Awareness - Kaplan University Dept. of Public Health
Cancer Awareness - Kaplan University Dept. of Public Health
 
Call-on Congress 2014 Heather Hampel: Genetics
Call-on Congress 2014 Heather Hampel: GeneticsCall-on Congress 2014 Heather Hampel: Genetics
Call-on Congress 2014 Heather Hampel: Genetics
 
Geriatric Oncology_ Treatment, Assessment and Management ( PDFDrive ).pdf
Geriatric Oncology_ Treatment, Assessment and Management ( PDFDrive ).pdfGeriatric Oncology_ Treatment, Assessment and Management ( PDFDrive ).pdf
Geriatric Oncology_ Treatment, Assessment and Management ( PDFDrive ).pdf
 
Rodger - Prostate cancer mortality outcomes and patterns of primary treatment...
Rodger - Prostate cancer mortality outcomes and patterns of primary treatment...Rodger - Prostate cancer mortality outcomes and patterns of primary treatment...
Rodger - Prostate cancer mortality outcomes and patterns of primary treatment...
 
Precision Medicine at MSU
Precision Medicine at MSUPrecision Medicine at MSU
Precision Medicine at MSU
 
33b-Cancer-21-6-2022.pdf
33b-Cancer-21-6-2022.pdf33b-Cancer-21-6-2022.pdf
33b-Cancer-21-6-2022.pdf
 
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast ...
 
MedicalResearch.com Top Medical Research Interview August 14 2015
MedicalResearch.com Top Medical Research Interview August 14 2015MedicalResearch.com Top Medical Research Interview August 14 2015
MedicalResearch.com Top Medical Research Interview August 14 2015
 
When reducing cancer risk in our population, let’s not exacerbate disparities
When reducing cancer risk in our population, let’s not exacerbate disparitiesWhen reducing cancer risk in our population, let’s not exacerbate disparities
When reducing cancer risk in our population, let’s not exacerbate disparities
 
Academic Detailing v01.13.17
Academic Detailing v01.13.17Academic Detailing v01.13.17
Academic Detailing v01.13.17
 
Cancer hospitals in illinois
Cancer hospitals in illinoisCancer hospitals in illinois
Cancer hospitals in illinois
 

More from OSUCCC - James

In Vitro ADMET Considerations for Drug Discovery and Lead Generation
In Vitro ADMET Considerations for Drug Discovery and Lead GenerationIn Vitro ADMET Considerations for Drug Discovery and Lead Generation
In Vitro ADMET Considerations for Drug Discovery and Lead Generation
OSUCCC - James
 
Cell-Based Ion Channel and Cardiac Safety Assays
Cell-Based Ion Channel and Cardiac Safety AssaysCell-Based Ion Channel and Cardiac Safety Assays
Cell-Based Ion Channel and Cardiac Safety Assays
OSUCCC - James
 
In-Vivo Safety - Pre Ind Drug Development
In-Vivo Safety - Pre Ind Drug DevelopmentIn-Vivo Safety - Pre Ind Drug Development
In-Vivo Safety - Pre Ind Drug Development
OSUCCC - James
 
The Path from Chemical Tool to Approvable Drug
The Path from Chemical Tool to Approvable DrugThe Path from Chemical Tool to Approvable Drug
The Path from Chemical Tool to Approvable Drug
OSUCCC - James
 
Target Validation / Biochemical and Cellular Assay Development
Target Validation / Biochemical and Cellular Assay Development Target Validation / Biochemical and Cellular Assay Development
Target Validation / Biochemical and Cellular Assay Development
OSUCCC - James
 
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
OSUCCC - James
 
Ohio State's ASH Review 2017 - Blood and Marrow Transplantation
Ohio State's ASH Review 2017 - Blood and Marrow TransplantationOhio State's ASH Review 2017 - Blood and Marrow Transplantation
Ohio State's ASH Review 2017 - Blood and Marrow Transplantation
OSUCCC - James
 
Ohio State's ASH Review 2017 - Update in Myeloma
Ohio State's ASH Review 2017 - Update in MyelomaOhio State's ASH Review 2017 - Update in Myeloma
Ohio State's ASH Review 2017 - Update in Myeloma
OSUCCC - James
 
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
OSUCCC - James
 
Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...
Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...
Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...
OSUCCC - James
 
ASCO 2016 Review Neuro-oncology
ASCO 2016 Review Neuro-oncologyASCO 2016 Review Neuro-oncology
ASCO 2016 Review Neuro-oncology
OSUCCC - James
 
Survivorship Care Plans
Survivorship Care PlansSurvivorship Care Plans
Survivorship Care Plans
OSUCCC - James
 
Cancer Survivorship Visit
Cancer Survivorship VisitCancer Survivorship Visit
Cancer Survivorship Visit
OSUCCC - James
 
Triage Cancer
Triage CancerTriage Cancer
Triage Cancer
OSUCCC - James
 
Survivorship Issues Genetics 2016
Survivorship Issues Genetics 2016Survivorship Issues Genetics 2016
Survivorship Issues Genetics 2016
OSUCCC - James
 
Older Adult Survivorship
Older Adult SurvivorshipOlder Adult Survivorship
Older Adult Survivorship
OSUCCC - James
 
Rehabilitation Issues in Breast Cancer Survivorship
Rehabilitation Issues in Breast Cancer SurvivorshipRehabilitation Issues in Breast Cancer Survivorship
Rehabilitation Issues in Breast Cancer Survivorship
OSUCCC - James
 
OT Case Study
OT Case StudyOT Case Study
OT Case Study
OSUCCC - James
 
Measuring for Lower Extremity Compression Garments
Measuring for Lower Extremity Compression GarmentsMeasuring for Lower Extremity Compression Garments
Measuring for Lower Extremity Compression Garments
OSUCCC - James
 
SLP Case Study
SLP Case StudySLP Case Study
SLP Case Study
OSUCCC - James
 

More from OSUCCC - James (20)

In Vitro ADMET Considerations for Drug Discovery and Lead Generation
In Vitro ADMET Considerations for Drug Discovery and Lead GenerationIn Vitro ADMET Considerations for Drug Discovery and Lead Generation
In Vitro ADMET Considerations for Drug Discovery and Lead Generation
 
Cell-Based Ion Channel and Cardiac Safety Assays
Cell-Based Ion Channel and Cardiac Safety AssaysCell-Based Ion Channel and Cardiac Safety Assays
Cell-Based Ion Channel and Cardiac Safety Assays
 
In-Vivo Safety - Pre Ind Drug Development
In-Vivo Safety - Pre Ind Drug DevelopmentIn-Vivo Safety - Pre Ind Drug Development
In-Vivo Safety - Pre Ind Drug Development
 
The Path from Chemical Tool to Approvable Drug
The Path from Chemical Tool to Approvable DrugThe Path from Chemical Tool to Approvable Drug
The Path from Chemical Tool to Approvable Drug
 
Target Validation / Biochemical and Cellular Assay Development
Target Validation / Biochemical and Cellular Assay Development Target Validation / Biochemical and Cellular Assay Development
Target Validation / Biochemical and Cellular Assay Development
 
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
Intro to Ohio State's Drug Development Bootcamp: Practical Aspects of Positio...
 
Ohio State's ASH Review 2017 - Blood and Marrow Transplantation
Ohio State's ASH Review 2017 - Blood and Marrow TransplantationOhio State's ASH Review 2017 - Blood and Marrow Transplantation
Ohio State's ASH Review 2017 - Blood and Marrow Transplantation
 
Ohio State's ASH Review 2017 - Update in Myeloma
Ohio State's ASH Review 2017 - Update in MyelomaOhio State's ASH Review 2017 - Update in Myeloma
Ohio State's ASH Review 2017 - Update in Myeloma
 
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
Surgical (or Non-Surgical) Managment of Thyroid Cancer in the Era of "Over-Di...
 
Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...
Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...
Genetic predisposition to papillary thyroid cancer by Albert de la Chapelle, ...
 
ASCO 2016 Review Neuro-oncology
ASCO 2016 Review Neuro-oncologyASCO 2016 Review Neuro-oncology
ASCO 2016 Review Neuro-oncology
 
Survivorship Care Plans
Survivorship Care PlansSurvivorship Care Plans
Survivorship Care Plans
 
Cancer Survivorship Visit
Cancer Survivorship VisitCancer Survivorship Visit
Cancer Survivorship Visit
 
Triage Cancer
Triage CancerTriage Cancer
Triage Cancer
 
Survivorship Issues Genetics 2016
Survivorship Issues Genetics 2016Survivorship Issues Genetics 2016
Survivorship Issues Genetics 2016
 
Older Adult Survivorship
Older Adult SurvivorshipOlder Adult Survivorship
Older Adult Survivorship
 
Rehabilitation Issues in Breast Cancer Survivorship
Rehabilitation Issues in Breast Cancer SurvivorshipRehabilitation Issues in Breast Cancer Survivorship
Rehabilitation Issues in Breast Cancer Survivorship
 
OT Case Study
OT Case StudyOT Case Study
OT Case Study
 
Measuring for Lower Extremity Compression Garments
Measuring for Lower Extremity Compression GarmentsMeasuring for Lower Extremity Compression Garments
Measuring for Lower Extremity Compression Garments
 
SLP Case Study
SLP Case StudySLP Case Study
SLP Case Study
 

Recently uploaded

CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
Sachin Sharma
 
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
rightmanforbloodline
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
Canadian Cancer Survivor Network
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
CANSA The Cancer Association of South Africa
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPYRECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
Isha Jaiswal
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
Chandrima Spa Ajman
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
Rommel Luis III Israel
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
Radhika kulvi
 
Under Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's StrategyUnder Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's Strategy
Kenneth Kruk
 
The positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experienceThe positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experience
SGRT Community
 
KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
NX Healthcare
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
ssuser787e5c1
 
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
blessyjannu21
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
Dr Rachana Gujar
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
Brian Frerichs
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
Azreen Aj
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
NEHA GUPTA
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
VITASAuthor
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 

Recently uploaded (20)

CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
 
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPYRECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
RECENT ADVANCES IN BREAST CANCER RADIOTHERAPY
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
 
Under Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's StrategyUnder Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's Strategy
 
The positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experienceThe positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experience
 
KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
 
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 

ASCO Review 2016 Addressing Health Disparities